Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Akron, OH
NPI: 1346458650Primary Practice Location
SUMMA HEALTH SYSTEM
141 N Forge St, Akron, OH
Primary Employer
Summa Health Medical Group
summahealth.org
HQ Phone
Get M.D. Bradley's Phone Numberphone_androidMobile
Get M.D. Bradley's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 139 | 203 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 93 | 231 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 35 | 55 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 28 | 28 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 27 | 30 |
Authors: Carole Fakhry, Quynh-Thu Le, Suresh Nair, Elaine Bigelow, Maura Gillison, David Rosenthal, Steven Frank, Jimmy Caudell, Yuhchyau Chen
Publication Date: 2021-11-03
EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data.
Authors: Nathan Pennell, Rom Leidner
Publication Date: 2012-12-16
Simpson's paradox - aggregating and partitioning populations in health disparities of lung cancer patients.
Authors: Rom Leidner, Afshin Dowlati
Publication Date: 2012-01-17
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, OTHER: Fludeoxyglucose F-18, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, RADIATION: Intensity-Modulated Radiation Therapy, PROCEDURE: Computed Tomography, OTHER: Patient Observation, PROCEDURE: Echocardiography Test
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, BIOLOGICAL: Nivolumab, DRUG: Cisplatin, DRUG: Etoposide
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, DRUG: Cisplatin, DRUG: Paclitaxel, DRUG: Etoposide, BIOLOGICAL: Durvalumab, DRUG: Pemetrexed Disodium
